Meningeal Neoplasms

Top drugs studied for this disease

All Approvals Safety alerts Label changes Trial results Research Guidance Withdrawals

EMA withdrawal · 2023-04-03
EMA Withdrawn: DepoCyte (cytarabine) — Pacira Limited
EMA has withdrawn DepoCyte (cytarabine) for meningeal neoplasms from Pacira Limited.